ABBV-295
A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives
AbbVie · Phase 1 · Completed · Enrollment 20
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| ABBV-295 with Levonorgestrel and Ethinyl Estradiol | Healthy Volunteer | n/r | n/r | n/r | n/r |